Organ-on-chip platforms for nanoparticle toxicity and efficacy assessment: Advancing beyond traditional in vitro and in vivo models
Source abstract
Abstract
Nanoparticles (NPs) have unique properties, such as their high surface-to-volume ratio, nanoscale size, and functionalization potential, make them promising for a variety of biomedical applications, including drug delivery, diagnostics, and targeted therapy. With rapid progress in NPs research, increasing efforts are being made to develop new technologies for in vitro modeling and analysis of the efficacy and safety of nanotherapeutics in human physiological systems. Organ-on-chip (OoC) platforms are a cutting-edge alternative to traditional in vitro and in vivo models that provide a ground-breaking way to evaluate the toxicity and therapeutic efficacy of NPs. This review explores the advancements and achievements in OoC technology, focusing on explore the recent advances in healthy and diseases models and its potential to enhance NPs safety and efficacy. By simulating human biological systems, OoC help identify negative effects and mechanisms of action, reducing preclinical research failures and promoting targeted treatments. These platforms can cut down on drug development time and costs, making them invaluable for personalized medicine. However, challenges such as scalability and regulatory hurdles must be addressed before OoC can become a standard in NPs research and drug development. This review offers a critical and current summary of recent developments in OoC models for nanoformulation screening, emphasizing how they affect preclinical results and how they might be incorporated into the development of nanomedicine. It seeks to assist researchers and professionals in the industry in making well-informed choices regarding the use of these platforms.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: 3D Printing in Biomedical Research · Innovative Microfluidic and Catalytic Techniques Innovation · Neuroscience and Neural Engineering
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Organ-on-Chip approaches for intestinal 3D in vitro modeling10.1016/j.jcmgh.2021.08.015 ↗
2. Microfluidic Organ-on-a-Chip models of human intestine10.1016/j.jcmgh.2017.12.010 ↗
3. rgan-on-a-chip microengineering for bio-mimicking disease models and revolutionizing drug discovery
4. Cancer models on chip: paving the way to large‐scale trial applications10.1002/adma.202300692 ↗
5. Vascularized 3D human skin models in the forefront of dermatological research10.1002/adhm.202303351 ↗
6. A new approach of using Organ-on-a-Chip and fluid–structure interaction modeling to investigate biomechanical characteristics in tissue-engineered blood vessels
7. Current developments and applications of microfluidic technology toward clinical translation of nanomedicines10.1016/j.addr.2017.08.003 ↗
8. Microfluidic devices: a tool for nanoparticle synthesis and performance evaluation10.1021/acsnano.3c01117 ↗
9. Human organs-on-chips for disease modelling, drug development and personalized medicine10.1038/s41576-022-00466-9 ↗
10. Advancement of organ-on-chip towards next generation medical technology
11. Organ-on-Chip systems as a model for nanomedicine10.1039/D3NR01661G ↗
12. Organ‐on‐a‐Chip: a preclinical microfluidic platform for the progress of nanomedicine10.1002/smll.202003517 ↗
13. Organ-on-a-Chip platforms for accelerating the evaluation of nanomedicine
14. Oral bioavailability of insulin contained in polysaccharide nanoparticles10.1021/bm0703923 ↗
15. Facts and evidences on the lyophilization of polymeric nanoparticles for drug delivery10.1016/j.jconrel.2016.01.034 ↗
16. Advancements in organ-on-a-chip systems: materials, characterization, and applications10.1002/slct.202403611 ↗
17. Multifunctional magnetic iron oxide nanoparticles: diverse synthetic approaches, surface modifications, cytotoxicity towards biomedical and industrial applications
18. Protective value of sevoflurane to glycocalyx under low shear stress based on a microfluidic vessel chip
19. A three-dimensional (3D) liver–kidney on a chip with a biomimicking circulating system for drug safety evaluation10.1039/D3LC00980G ↗
20. Liver-on-Chip model and application in predictive genotoxicity and mutagenicity of drugs10.1016/j.mrgentox.2024.503762 ↗
21. A human liver organoid screening platform for DILI risk prediction
22. Generation and culture of cardiac microtissues in a microfluidic chip with a reversible open top enables electrical pacing, dynamic drug dosing and endothelial cell co‐culture10.1002/admt.202101355 ↗
23. Micro-engineered heart tissues on-Chip with heterotypic cell composition display self-organization and improved cardiac function
24. 3D in vitro blood‐brain‐barrier model for investigating barrier insults10.1002/advs.202205752 ↗
25. The contribution of inflammatory astrocytes to BBB impairments in a brain-chip model of parkinson's disease10.1038/s41467-023-39038-8 ↗
26. Neuro‐Glia‐Vascular‐on‐a‐Chip system to assess aggravated neurodegeneration via brain endothelial cells upon exposure to diesel exhaust particles
27. V vascular units as advanced living materials for Bottom-Up engineering of perfusable 3D microvascular networks
28. A cell pre-wrapping seeding technique for hydrogel-based tubular Organ-On-A-Chip10.1002/advs.202400970 ↗
29. Stem cell-derived Eessels-on-Chip for cardiovascular disease modeling10.1016/j.celrep.2024.114008 ↗
30. Microfluidic system for generating a three-dimensional (3D) vascularized Islet-on-a-Chip model10.1016/j.snb.2024.136302 ↗
31. Self-assembling 3D vessel-on-chip model with hiPSC-Derived astrocytes10.1016/j.stemcr.2024.05.006 ↗
32. Barrier-free, open-top microfluidic chip for generating two distinct, interconnected 3D microvascular networks10.1038/s41598-024-74493-3 ↗
33. The effect of ultrasound-assisted thrombolysis studied in Blood-on-a-Chip10.1111/aor.14731 ↗
34. Platelet adhesion and activation in an ECMO Thrombosis-on-a-Chip model
35. Microfluidic platform for the reproduction of hypoxic vascular microenvironments10.1038/s41598-023-32334-9 ↗
36. A tempo-spatial controllable microfluidic shear-stress generator for In-Vitro mimicking of the thrombus10.1186/s12951-024-02334-6 ↗
37. Spatiotemporally mapped endothelial dysfunction at bifurcations in a coronary artery-on-a-chip
38. Utilization of an Artery-on-a-Chip to unravel novel regulators and therapeutic targets in vascular diseases10.1002/adhm.202302907 ↗
39. Using Organ-on-a-Chip technology to study haemorrhagic activities of snake venoms on endothelial tubules
40. Physiological platelet aggregation assay to mitigate drug-induced thrombocytopenia using a microphysiological system10.1038/s41598-024-64063-y ↗
41. Automated fabrication of a scalable Heart-on-a-Chip device by 3D printing of thermoplastic elastomer nanocomposite and hot embossing
42. Heart-on-a-Chip model of epicardial–myocardial interaction in ischemia reperfusion injury
43. Timely delivery of cardiac mmRNAs in microfluidics enhances cardiogenic programming of human pluripotent stem cells10.3389/fbioe.2022.871867 ↗
44. V vascularized hiPSC-Derived 3D cardiac microtissue on chip10.1016/j.stemcr.2023.06.001 ↗
45. Bioinspired optical and electrical dual-responsive Heart-on-a-Chip for hormone testing10.1016/j.scib.2023.04.010 ↗
46. SARS-CoV-2 pathogenesis in an angiotensin II–Induced Heart-on-a-Chip disease model and extracellular vesicle screening10.1073/pnas.2403581121 ↗
47. Spaceflight-induced contractile and mitochondrial dysfunction in an automated Heart-on-a-chip platform10.1073/pnas.2404644121 ↗
48. Hydrogel-integrated Heart-on-a-Chip platform for assessment of myocardial ischemia markers10.1021/acsomega.4c02121 ↗
49. A biomimetic cardiac Fibrosis-on-a-Chip as a visible disease model for evaluating mesenchymal stem cell-derived exosome therapy10.1021/acsnano.3c09368 ↗
50. Blood–brain barrier injury and neuroinflammation induced by SARS-CoV-2 in a lung–brain microphysiological system10.5772/intechopen.100663 ↗
51. Protective effects of Omega-3 fatty acids in a blood–brain barrier-on-chip model and on postoperative delirium-like behaviour in mice10.1016/j.bja.2022.05.025 ↗
52. In situ detection of neuroinflammation using multicellular 3D neurovascular-unit-on-a-chip10.1002/adfm.202304382 ↗
53. A tissue chip with integrated digital immunosensors: in situ brain endothelial barrier cytokine secretion monitoring10.1016/j.bios.2022.115030 ↗
54. A method to generate perfusable physiologic-like vascular channels within a liver-on-chip model10.1063/5.0170606 ↗
55. Human nonalcoholic steatohepatitis on a chip10.1002/hep4.1647 ↗
56. Microneedle array facilitates hepatic sinusoid construction in a large-scale liver-acinus-chip microsystem10.1038/s41378-023-00544-w ↗
57. A novel milli-fluidic liver tissue chip with continuous recirculation for predictive pharmacokinetics applications10.1208/s12248-023-00870-x ↗
58. Synergistic modulation of a tunable microenvironment to fabricate a liver fibrosis chip for drug testing10.1021/acsbiomaterials.3c00213 ↗
59. A high-throughput gut-on-chip platform to study the epithelial responses to enterotoxins10.1038/s41598-024-56520-5 ↗
60. Addressing the ADME challenges of compound loss in a PDMS-based gut-on-chip microphysiological system10.3390/pharmaceutics16030296 ↗
61. Phage-mediated digestive decolonization in a Gut-on-a-Chip model: a tale of gut-specific bacterial prosperity10.3390/v16071047 ↗
62. Head-to-Head comparison of Caco-2 transwell and Gut-on-a-Chip models for assessing oral peptide formulations10.1021/acs.molpharmaceut.4c00210 ↗
63. Dose and route dependent effects of the mycotoxin deoxynivalenol in a 3D Gut-on-a-Chip model with flow, toxicol
64. Ginseng oligopeptides improve the intestinal physiology and promote the antioxidant capacity of the Gut-on-a-Chip model10.3390/nu16060845 ↗
65. Critical suitability evaluation of Caco-2 cells for Gut-on-a-Chip10.1021/acsami.4c11409 ↗
66. 3D inkjet-bioprinted Lung-on-a-Chip10.1021/acsbiomaterials.3c00089 ↗
67. Sentinel supervised Lung-on-a-Chip: a new environmental toxicology platform for nanoplastic-induced lung injury10.1016/j.jhazmat.2023.131962 ↗
68. A stretchable human lung-on-chip model of alveolar inflammation for evaluating anti‐inflammatory drug response
69. Ektnitphong · 2024
70. An immunocompetent human Kidney-on-a-Chip model to study renal inflammation and immune-mediated injury10.1088/1758-5090/ad9fdf ↗
71. Evaluating nephrotoxicity reduction in a novel polymyxin B formulation: insights from a 3D Kidney-on-a-Chip model10.1128/aac.00219-24 ↗
72. Lung-on-a-Chip composed of styrene-butadiene-styrene nano-Fiber/Porous PDMS composite membranes with cyclic triaxial stimulation10.1007/s10404-024-02739-7 ↗
73. Circulating extracellular vesicles in human cardiorenal syndrome promote renal injury in a kidney-on-chip system10.1172/jci.insight.165172 ↗
74. Fabrication of nephrotoxic model by Kidney-on-a-Chip implementing renal proximal tubular function in vitro10.1007/s13206-024-00166-y ↗
75. Kidney-on-the-Chip approach using primary human tubular cells in a 3D Co-Culture system10.1093/ndt/gfaa140.MO068 ↗
76. Decoupling shear stress and pressure effects in the biomechanics of autosomal dominant polycystic kidney disease using a perfused kidney-on-chip10.1016/j.actbio.2025.03.022 ↗
77. A perfusable vascularized full-thickness skin model for potential topical and systemic applications10.1088/1758-5090/abfca8 ↗
78. Design of an integrated microvascularized human Skin-on-a-Chip tissue equivalent model10.3389/fbioe.2022.915702 ↗
79. Full-thickness human skin-on-chip with enhanced epidermal morphogenesis and barrier function10.1016/j.mattod.2017.11.002 ↗
80. Environmentally controlled microfluidic system enabling immune cell flow and activation in an endothelialised skin‐on‐chip10.1002/adhm.202400750 ↗
81. Modeling human HSV infection via a vascularized immune-competent skin-on-chip platform
82. Modeling of three-dimensional innervated epidermal like-layer in a microfluidic chip-based coculture system10.1038/s41467-023-37187-4 ↗
83. Analysis of drug efficacy for inflammatory skin on an organ-chip system10.3389/fbioe.2022.939629 ↗
84. Patient-derived pancreatic Cancer-on-a-Chip recapitulates the tumor microenvironment, microsyst
85. A human organotypic microfluidic tumor model permits investigation of the interplay between patient-derived fibroblasts and breast cancer cells10.1158/0008-5472.CAN-18-2293 ↗
86. Magnetically integrated tumor–vascular interface system to mimic pro-angiogenic endothelial dysregulations for On-Chip drug testing10.1021/acsami.4c01766 ↗
87. Assessing personalized responses to Anti-PD-1 treatment using patient-derived lung Tumor-on-Chip
88. Evaluation of drug resistance for EGFR-TKIs in lung cancer via multicellular Lung-on-a-Chip10.1016/j.ejps.2024.106805 ↗
89. A novel 3D vascular assay for evaluating angiogenesis across porous membranes10.1016/j.biomaterials.2020.120592 ↗
90. Microfluidic tumor–vascular model to study breast cancer cell invasion and intravasation10.1002/adhm.201701257 ↗
91. Hydrophobic surface induced pro-metastatic cancer cells for In Vitro extravasation models
92. A Metastasis-on-a-Chip approach to explore the sympathetic modulation of breast cancer bone metastasis
93. An engineered Tumor-on-a-Chip device with breast cancer–immune cell interactions for assessing T-cell recruitment10.1158/0008-5472.CAN-19-0342 ↗
94. The effects of monocytes on tumor cell extravasation in a 3D vascularized microfluidic model10.1016/j.biomaterials.2018.03.005 ↗
95. Breast cancer-on-chip for patient-specific efficacy and safety testing of CAR-T cells10.1016/j.stem.2024.04.018 ↗
96. Endothelial regulation of drug transport in a 3D vascularized tumor model10.1002/adfm.202002444 ↗
97. Red blood cell passage through deformable interendothelial slits in the spleen: insights into splenic filtration and hemodynamics10.1016/j.compbiomed.2024.109198 ↗
98. Signaling-biophysical modeling unravels mechanistic control of red blood cell phagocytosis by macrophages in sickle cell disease10.1093/pnasnexus/pgae031 ↗
99. Microfluidic study of retention and elimination of abnormal red blood cells by human spleen with implications for sickle cell disease10.1073/pnas.2217607120 ↗
100. Self-assembled human placental model from trophoblast stem cells in a dynamic Organ-on-a-Chip system10.1111/cpr.13469 ↗